Live Breaking News & Updates on Roceeds Slno Us8342033094

Stay updated with breaking news from Roceeds slno us8342033094. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Soleno Therapeutics, Inc. announced that it expects to receive $59.89 million in funding from Abingworth LLP, Vivo Capital, LLC, Nantahala Capital Management, LLC, Brightleaf Capital, Corbin Capital Partners, L.P.

Soleno Therapeutics, Inc. announced it has entered into a securities purchase agreement for a private placement of 22,600,000 common shares at a price of $2.65 per share for gross proceeds $59,890,000. | ....

Manish Bhatnagar , James Mackaness , Soleno Therapeutics Inc , Blackwell Partners , Vivo Capital , Drug Administration , Nantahala Capital Management , Soleno Therapeutics , Abingworth Bioventures , Nantahala Capital Partners , Pinehurst Partners , Nc Stock Exchange , Press Release , Roceeds Slno Us8342033094 ,